You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD28

Showing 1 - 25 of 8,782
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

    Not yet recruiting
    • Prostate Cancer
    • Radical Prostatectomy
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 10, 2023

    Immune Thrombocytopenia Trial in Sohag (Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR
    • Sohag, Egypt
      Sohag University Hospital
    Jul 19, 2022

    CNS Lymphoma Trial in Duarte (procedure, biological, drug)

    Recruiting
    • Central Nervous System Lymphoma
    • Aspiration
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

    Not yet recruiting
    • Advanced Prostate Cancer
    • Lyon, France
    • +2 more
    Oct 18, 2023

    Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

    Not yet recruiting
    • Glioblastoma Multiforme of Brain
    • CHM-1101 CAR-T cells
    • Duarte, California
      City of Hope Medical Center
    Dec 19, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Acalabrutinib
    • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
    • Duarte, California
      City of Hope Comprehensive Cancer Center
    Jun 16, 2022

    Recurrent DLBCL, Recurrent Mantle Cell Lymphoma, Refractory DLBCL Trial in Duarte (Autologous

    Active, not recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +4 more
    • Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Mar 28, 2022

    Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin

    Recruiting
    • Recurrent Glioblastoma
    • +3 more
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2022

    Kidney Transplantation, Renal Transplant Recipients Trial in Atlanta (Lulizumab, Tacrolimus, Thymoglobulin®)

    Not yet recruiting
    • Kidney Transplantation
    • Renal Transplant Recipients
    • Lulizumab
    • +5 more
    • Atlanta, Georgia
      Emory University Hospital
    Sep 22, 2021

    Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • CD19.CAR-CD28Z T Cells - dose escalation 2
    • CD19.CAR-CD28Z T Cells - dose escalation 1
    • Houston, Texas
    • +1 more
    Feb 10, 2022

    Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

    Active, not recruiting
    • Adult Acute Myeloid Leukemia in Remission
    • +12 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

    Not yet recruiting
    • B-cell Non-Hodgkins Lymphoma (B-NHL)
    • (no location specified)
    Jan 5, 2023

    Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

    Recruiting
    • Lymphoma
    • +2 more
    • Kappa CD28 T cells
    • Houston, Texas
    • +1 more
    Jan 31, 2022

    Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

    Recruiting
    • Mantle Cell Lymphoma
    • +5 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Nov 19, 2021

    Objective Response Rate Trial in Hangzhou (CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine)

    Recruiting
    • Objective Response Rate
    • CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jun 5, 2021

    Acute Myeloid Leukemia Trial in Valencia (AFM28)

    Recruiting
    • Acute Myeloid Leukemia
    • Valencia, Spain
      Hospital Universitari i Politècnic La Fe
    Apr 5, 2023

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Kidney Transplantation Trial in Nantes (FR104)

    Recruiting
    • Kidney Transplantation
    • Nantes, France
      Blancho
    Mar 24, 2022

    B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

    Recruiting
    • B-Cell Lymphoma
    • +4 more
    • 19(T2)28z1xx TRAC T cell
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Feb 24, 2023

    Chronic Lymphocytic Leukemia (CLL), Relapsed, Refractory Trial in New York (EGFRt/19-28z/4-1BBL CAR T cells)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +2 more
    • EGFRt/19-28z/4-1BBL CAR T cells
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Multiple Myeloma Trial in Philadelphia, Houston (CD3/CD28)

    Completed
    Has Results
    • Multiple Myeloma
    • CD3/CD28
    • Philadelphia, Pennsylvania
    • +1 more
    Dec 2, 2020

    B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

    Terminated
    • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
    • +16 more
    • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 28, 2021

    Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • +2 more
    • Daratumumab
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Abatacept
    • +3 more
    • Buffalo, New York
    • +2 more
    Dec 22, 2022